Mitsuo Shimada

A Risk Model for Esophagectomy Using Data of 5354 Patients Included in a Japanese Nationwide Web-Based Database

Hiroya Takeuchi, Hiroaki Miyata, Mitsukazu Gotoh et al. · Annals of Surgery · 2014 · 588 citations

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

Norihiro Kokudo, Nobuyuki Takemura, Kiyoshi Hasegawa et al. · Hepatology Research · 2019 · 523 citations

Pathology, Fourth Version, Clinical Practice Guidelines +18

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

Hideki Ueno, T Kosuge, Y Matsuyama et al. · British Journal of Cancer · 2009 · 435 citations · Full text

Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume

Ken Shirabe, Mitsuo Shimada, Tomonobu Gion et al. · Journal of the American College of Surgeons · 1999 · 428 citations · Full text

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8